CompletedNot applicableNCT03541551

Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

Studying Congenital glaucoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
L.V. Prasad Eye Institute
Principal Investigator
senthil sirisha, MS
YES
Intervention
CTT with ologen® Collagen Matrix(procedure)
Enrollment
44 enrolled
Eligibility
3 years · All sexes
Timeline
2018 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03541551 on ClinicalTrials.gov

Other trials for Congenital glaucoma

Additional recruiting or active studies for the same condition.

See all trials for Congenital glaucoma →

← Back to all trials